Position in FTRE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,301,060
+$6,515,252 QoQ
Shares Held
821,900
-0.6% QoQ
Ownership
0.864%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#28
of 334 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LORD, ABBETT & CO. LLC holds $1,265,371,768 across 32 Biotechnology names. FTRE ranks #23 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
281,500 | $151,151,425 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
789,241 | $147,809,054 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
3,431,030 | $132,780,861 | |
| 4 | ARGX |
Argenx SE
|
108,253 | $100,433,885 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
166,581 | $82,745,780 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
540,977 | $63,332,177 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
398,994 | $48,908,684 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
590,074 | $48,132,336 |
All Filings in FTRE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,301,060 | 821,900 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,785,808 | 826,519 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $12,176,223 | 705,868 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,985,591 | 592,113 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||